GKOS Insider Trading
Insider Ownership Percentage: 6.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $10,507,747.68
Glaukos Share Price & Price History
Current Price: $90.15
Price Change: ▲ Price Increase of +1.352 (1.52%)
As of 04/17/2025 04:59 PM ET
Glaukos Insider Trading History
Glaukos Institutional Trading History
Data available starting January 2016
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
Read More on Glaukos
Today's Range
Now: $90.15
52 Week Range
Now: $90.15
Volume
662,537 shs
Average Volume
638,778 shs
Market Capitalization
$5.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.88
Who are the company insiders with the largest holdings of Glaukos?
Glaukos' top insider investors include:
- Thomas William Burns (CEO)
- Joseph E Gilliam (COO)
- Tomas Navratil (Insider)
- Alex R Thurman (CFO)
- Marc Stapley (Director)
- Mark J Foley (Director)
- Gilbert H Kliman (Director)
- Aimee S Weisner (Director)
Learn More about top insider investors at Glaukos.
Who are the major institutional investors of Glaukos?
Which institutional investors are selling Glaukos stock?
Within the previous quarter, GKOS stock was sold by these institutional investors:
- Trust Point Inc.
- Caldwell Sutter Capital Inc.
- GAMMA Investing LLC
- Yousif Capital Management LLC
- Rhumbline Advisers
During the previous year, company insiders that have sold Glaukos company stock include:
- Thomas William Burns (CEO)
- Joseph E Gilliam (COO)
- Tomas Navratil (Insider)
- Alex R Thurman (CFO)
- Marc Stapley (Director)
- Mark J Foley (Director)
Learn More investors selling Glaukos stock.
Which institutional investors are buying Glaukos stock?
Within the previous quarter, GKOS stock was purchased by institutional investors including:
- GAMMA Investing LLC
- Harbor Capital Advisors Inc.
- Handelsbanken Fonder AB
- Exchange Traded Concepts LLC
- Elevation Point Wealth Partners LLC
- SG Americas Securities LLC
- Versant Capital Management Inc
- Whipplewood Advisors LLC